Old National Bancorp’s United Therapeutics UTHR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-3,431
Closed -$374K 609
2018
Q4
$374K Buy
3,431
+14
+0.4% +$1.62K 0.02% 387
2018
Q3
$437K Sell
3,417
-17
-0.5% -$2.1K 0.02% 403
2018
Q2
$389K Hold
3,434
0.02% 423
2018
Q1
$386K Buy
3,434
+9
+0.3% +$1.14K 0.02% 412
2017
Q4
$507K Hold
3,425
0.03% 366
2017
Q3
$401K Sell
3,425
-87
-2% -$11.1K 0.02% 412
2017
Q2
$456K Sell
3,512
-529
-13% -$66K 0.03% 372
2017
Q1
$547K Sell
4,041
-113
-3% -$17.1K 0.03% 338
2016
Q4
$596K Hold
4,154
0.03% 319
2016
Q3
$491K Buy
4,154
+920
+28% +$111K 0.03% 363
2016
Q2
$343K Buy
3,234
+2
+0.1% +$223 0.02% 440
2016
Q1
$360K Buy
3,232
+809
+33% +$102K 0.02% 426
2015
Q4
$379K Hold
2,423
0.02% 418
2015
Q3
$318K Buy
2,423
+218
+10% +$35K 0.02% 457
2015
Q2
$384K Buy
2,205
+80
+4% +$14.4K 0.02% 429
2015
Q1
$366K Sell
2,125
-876
-29% -$134K 0.02% 453
2014
Q4
$389K Sell
3,001
-775
-21% -$99.9K 0.02% 384
2014
Q3
$486K Buy
3,776
+811
+27% +$83.6K 0.03% 322
2014
Q2
$262K Hold
2,965
0.02% 460
2014
Q1
$279K Buy
+2,965
New +$303K 0.03% 352

Other funds holding UTHR

Old National Bancorp's UTHR Position: Q1 2019 in Review

Old National Bancorp sold out of United Therapeutics (UTHR) in Q1 2019, closing a stake of 3,431 shares — an estimated $374K sold.

Old National Bancorp first reported a position in UTHR in Q1 2014 and held it in 20 quarters. The position peaked at $596K in Q4 2016. 378 funds tracked by Wall St. Rank hold UTHR as of Q1 2019.

  • Old National Bancorp reported no remaining United Therapeutics position as of Q1 2019 after selling out during the quarter.
  • Old National Bancorp sold 3,431 United Therapeutics shares in Q1 2019, an estimated $374K.
  • Old National Bancorp first reported a position in United Therapeutics in Q1 2014 and held it in 20 quarters.
  • Old National Bancorp's United Therapeutics position peaked at $596K in Q4 2016.
  • 378 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2019.

Based on Old National Bancorp's 13F filing for Q1 2019, filed 30 Apr 2019.